Algogenics Logo
Integrated Computational Biology & Assay PlatformExplore Workflow

Identify & Validate Drug Candidates Faster

AlgoGenics helps biotech and pharmaceutical teams identify and validate promising drug targets and candidate molecules faster by combining AI-driven computational biology with experimental validation.

From genomic variants and protein structures to druggable targets and candidate compounds—all in one integrated discovery workflow.

RUN A DISCOVERY SPRINT
Dr. Elena Vasquez
Prof. Marcus Chen
Dr. Aisha Patel
Dr. Jamal Okoro

Trusted by Leading Biotech & Pharma Researchers

Accelerating target validation at world-class oncology & rare disease labs

BROAD_INSTITUTESTANFORD_MEDICINEFRANCIS_CRICKMAX_PLANCKNOVARTIS_LABS
01
Variant Analysis

Genomic Variants

Map disease-associated variants and quantify pathogenicity with high-throughput AI models.

Integrated Agent
02
3D Structure Modeling

Protein Structures

Predict 3D conformational dynamics, mutation instability, and structural binding pockets.

Integrated Agent
03
Candidate Discovery

Druggable Targets

Evaluate target druggability, pocket affinity, and virtual candidate molecule screening.

Integrated Agent
04
Assay Validation

Wet-Lab Validation

Seamlessly connect computational hits with experimental assay protocols and telemetry.

Integrated Agent
Intelligence System v4.2.0

End-to-End Discovery Loop

A multi-agent autonomous chain designed to synthesize genomic raw data into validated molecular leads in under 120 seconds.

Input Console

Pre-validated Datasets
VCF_V4.2

Neural Telemetry

System initialized. Awaiting pipeline execution...
Variant Discovery & Annotation
Coverage:142x
Mapping Qual:60.0
In-Silico Protein Modeling
pLDDT Score:94.2
ΔΔG Stability:+4.1
Computational Lead Docking
Binding Aff:-9.8 kcal
Ligand Eff:0.44
Bio-Vault Secure Archiving
Latency:42ms
Encryption:GCM-256
Scientific Intelligence Synthesis
Source Count:14k+
Confidence:98.8%
Final Discovery Dossier
Dossier Size:12.4MB
Approval:Pending
Pipeline Ready
Select a sample dataset or upload raw genomic data to execute the discovery loop.
Active Target Vector:
Gene:EGFR
PDB Accession:6VXX
Druggability SiteScore:1.084
Proof of Druggability

EGFR Kinase Domain

Activating mutation in the kinase domain destabilizing the inactive conformation, enabling selective Type II allosteric inhibition.

3D Binding Pocket Mesh (6VXX)

Pocket Volume

442.1 ų

OPTIMAL POCKET

SiteMap Score

1.084

HIGH AFFINITY

Key Residues

Met790, Thr790, Lys745

+2 interaction sites

In-Silico Validation Summary

Target validation was achieved by executing molecular dynamics simulations across 10,000 conformational states using GPU micro-clusters.

Binding Pocket Confidence98.8%
Solvent Accessibility Index0.74

Integrated Genomic Reference Accessions

UniProt KnowledgebaseP00533
RCSB Protein Data Bank6VXX
NCBI ClinVar Mutation IDVCV000016613
gnomAD Allele Frequency0.0000142
H100 Compute Cluster: Active
Bio-Vault: Synced

© 2026 AlgoGenics - Autonomous Discovery-as-a-Service Protocol

Core Capability Architecture

Built for High-Stakes Genomic Research

Everything you need to run trusted, autonomous bioinformatics workflows at enterprise scale.

Autonomous

Agentic Workflow Orchestration

Agents autonomously plan, execute, and iterate through multi-step genomic analyses without manual intervention.

Defensible

Built-In Explainability

Every prediction comes with confidence scores, rationale reports, attention maps, and uncertainty quantification.

Live Stream

Real-Time Progress Tracking

Watch agents work step-by-step with live progress, intermediate results, and decision breakdowns.

3D Rendering

Advanced Visualizations

Interactive pathway maps, variant distributions, and protein structure overlays powered by cutting-edge rendering.

Compliance

Custom Report Generation

Export publication-ready reports with full methodology, statistical analysis, and bias warnings included.

Multi-User

Team Collaboration

Share agent runs, annotate results, and collaborate on analyses with role-based access control.

Intelligence FAQ

Common Queries

Everything you need to know about AlgoGenics and the transition to autonomous agentic discovery.

Traditional tools require manual step-by-step execution. Our agentic AI autonomously plans, executes, and iterates through multi-step analyses—like a bioinformatician working 24/7. They handle variant calling, pathogenicity scoring, and pathway integration in a single autonomous workflow.
AlgoGenics DaaS

From Raw Data to Accelerated Hit-to-Lead Identification.

Receive a custom Lead Candidate Dossier engineered specifically for your therapeutic target.

SECURE_DATA_SILO
GLP_COMPLIANT_REPORTING
ZERO_KNOWLEDGE_ENCRYPTION